Related Experiment Video
Updated: Nov 19, 2025

09:46
Megakaryocyte Differentiation and Platelet Formation from Human Cord Blood-derived CD34+ Cells
Published on: December 27, 2017
20.2K
[Pseudohyperkalemia and thrombocytosis]
Summary
Pseudo-hyperkalemia, often linked to thrombocytosis, can be mistaken for true hyperkalemia. Confirming potassium levels in heparinized blood tubes is crucial to avoid unnecessary treatments.
Area of Science:
- Clinical Medicine
- Hematology
- Nephrology
Background:
- Hyperkalemia is a common medical condition requiring prompt management.
- Potential causes include renal failure, adrenal insufficiency, cell lysis, and iatrogenic factors.
- Pseudo-hyperkalemia, arising from laboratory artifacts, must also be considered.
Purpose of the Study:
- To report cases of pseudo-hyperkalemia associated with thrombocytosis.
- To highlight the importance of differentiating pseudo-hyperkalemia from true hyperkalemia.
Main Methods:
- Case series involving three patients with thrombocytosis and non-symptomatic hyperkalemia.
- Comparison of kalemia levels in standard collection tubes versus heparinized tubes.
Main Results:
- Patients presented with thrombocytosis (1306–2404 G/L) and elevated serum potassium (6.1–7.7 mmol/L).
- Kalemia levels were normal (4.4–4.6 mmol/L) when blood was collected in heparin tubes, indicating pseudo-hyperkalemia.
- No specific treatment for hyperkalemia was required.
Conclusions:
- The concurrent presence of thrombocytosis and asymptomatic hyperkalemia suggests pseudo-hyperkalemia.
- Measuring kalemia in heparinized blood tubes is recommended for confirmation.
- Accurate diagnosis prevents unnecessary and potentially harmful treatments for hyperkalemia.
Related Concept Videos
Disorders of Hemostasis
1.6K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.6K
Chronic Kidney Disease II: Clinical Manifestations
337
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
337
Antihypertensive Drugs: Potassium-Sparing Diuretics
1.9K
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
1.9K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.2K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.2K
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
1.5K
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
1.5K
Dysrhythmias II: Classification of Tachyarrhythmias
323
Tachyarrhythmias are a type of dysrhythmia where the heart rate exceeds 100 beats per minute. Here are some common types of tachyarrhythmias:Sinus TachycardiaSinus tachycardia originates from increased impulses from the sinus node, leading to an elevated heart rate. It is often triggered by stress, fever, or exercise.Patients may experience palpitations, a sensation of a racing heart, dizziness, and chest discomfort.Causes and Risk Factors: Common causes include physical exertion, emotional...
323

